HK1120424A1 - Carbazole derivatives as functional 5-ht6 ligands - Google Patents
Carbazole derivatives as functional 5-ht6 ligandsInfo
- Publication number
- HK1120424A1 HK1120424A1 HK08113183.2A HK08113183A HK1120424A1 HK 1120424 A1 HK1120424 A1 HK 1120424A1 HK 08113183 A HK08113183 A HK 08113183A HK 1120424 A1 HK1120424 A1 HK 1120424A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- carbazole derivatives
- receptor
- ligands
- functional
- stereoisomers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
- Indole Compounds (AREA)
- Structures Or Materials For Encapsulating Or Coating Semiconductor Devices Or Solid State Devices (AREA)
- Photoreceptors In Electrophotography (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1504CH2005 | 2005-10-19 | ||
PCT/IN2006/000195 WO2007046111A1 (fr) | 2005-10-19 | 2006-06-09 | Derives de carbazole utiles en tant que ligands 5-ht6 fonctionnels |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1120424A1 true HK1120424A1 (en) | 2009-04-03 |
Family
ID=37054637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08113183.2A HK1120424A1 (en) | 2005-10-19 | 2008-12-03 | Carbazole derivatives as functional 5-ht6 ligands |
Country Status (24)
Country | Link |
---|---|
US (1) | US8143303B2 (fr) |
EP (1) | EP1948166B1 (fr) |
JP (1) | JP2009512681A (fr) |
KR (1) | KR101125820B1 (fr) |
CN (1) | CN101291670B (fr) |
AT (1) | ATE485040T1 (fr) |
AU (1) | AU2006305502B2 (fr) |
BR (1) | BRPI0619308A2 (fr) |
CA (1) | CA2626646C (fr) |
CY (1) | CY1111560T1 (fr) |
DE (1) | DE602006017722D1 (fr) |
DK (1) | DK1948166T3 (fr) |
EA (1) | EA014694B1 (fr) |
ES (1) | ES2354455T3 (fr) |
HK (1) | HK1120424A1 (fr) |
HR (1) | HRP20110041T1 (fr) |
NO (1) | NO341252B1 (fr) |
NZ (1) | NZ567865A (fr) |
PL (1) | PL1948166T3 (fr) |
PT (1) | PT1948166E (fr) |
RS (1) | RS51627B (fr) |
SI (1) | SI1948166T1 (fr) |
WO (1) | WO2007046111A1 (fr) |
ZA (1) | ZA200803118B (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2850707C (fr) * | 2011-10-03 | 2023-03-21 | The University Of Utah Research Foundation | Application d'antagonistes du recepteur 5-ht6 dans l'attenuation des deficits cognitifs lies au syndrome de down |
CN106045972B (zh) * | 2016-06-03 | 2018-11-16 | 中山大学 | 咔唑-利凡斯的明二联体及其药物组合物和应用 |
CN106749184B (zh) * | 2016-11-15 | 2020-07-17 | 中山大学 | 8-氨基喹啉-羟基咔唑杂联体,其制备方法及其药物组合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000034242A1 (fr) * | 1998-12-11 | 2000-06-15 | Virginia Commonwealth University | Ligands du recepteur de 5-ht6 selectifs |
EP1434578A1 (fr) * | 2001-10-09 | 2004-07-07 | PHARMACIA & UPJOHN COMPANY | Carbazoles arylsulfonyl tetrahydro et hexahydro substitues utiles comme ligands du recepteur 5-ht-6 |
-
2006
- 2006-06-09 EA EA200801114A patent/EA014694B1/ru not_active IP Right Cessation
- 2006-06-09 JP JP2008536206A patent/JP2009512681A/ja active Pending
- 2006-06-09 SI SI200630873T patent/SI1948166T1/sl unknown
- 2006-06-09 AT AT06766266T patent/ATE485040T1/de active
- 2006-06-09 AU AU2006305502A patent/AU2006305502B2/en not_active Ceased
- 2006-06-09 KR KR1020087010404A patent/KR101125820B1/ko active IP Right Grant
- 2006-06-09 WO PCT/IN2006/000195 patent/WO2007046111A1/fr active Application Filing
- 2006-06-09 PT PT06766266T patent/PT1948166E/pt unknown
- 2006-06-09 PL PL06766266T patent/PL1948166T3/pl unknown
- 2006-06-09 CN CN2006800390082A patent/CN101291670B/zh not_active Expired - Fee Related
- 2006-06-09 NZ NZ567865A patent/NZ567865A/en not_active IP Right Cessation
- 2006-06-09 DE DE602006017722T patent/DE602006017722D1/de active Active
- 2006-06-09 RS RS20110017A patent/RS51627B/en unknown
- 2006-06-09 ES ES06766266T patent/ES2354455T3/es active Active
- 2006-06-09 EP EP06766266A patent/EP1948166B1/fr active Active
- 2006-06-09 BR BRPI0619308-0A patent/BRPI0619308A2/pt not_active Application Discontinuation
- 2006-06-09 DK DK06766266.8T patent/DK1948166T3/da active
- 2006-06-09 US US12/083,707 patent/US8143303B2/en not_active Expired - Fee Related
- 2006-06-09 CA CA2626646A patent/CA2626646C/fr not_active Expired - Fee Related
-
2008
- 2008-04-09 ZA ZA2008/03118A patent/ZA200803118B/en unknown
- 2008-04-09 NO NO20081739A patent/NO341252B1/no not_active IP Right Cessation
- 2008-12-03 HK HK08113183.2A patent/HK1120424A1/xx not_active IP Right Cessation
-
2011
- 2011-01-20 CY CY20111100064T patent/CY1111560T1/el unknown
- 2011-01-20 HR HR20110041T patent/HRP20110041T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
US20100189646A1 (en) | 2010-07-29 |
RS51627B (en) | 2011-08-31 |
EP1948166B1 (fr) | 2010-10-20 |
JP2009512681A (ja) | 2009-03-26 |
HRP20110041T1 (hr) | 2011-02-28 |
CN101291670B (zh) | 2012-07-04 |
NZ567865A (en) | 2010-07-30 |
CA2626646C (fr) | 2011-03-01 |
AU2006305502A1 (en) | 2007-04-26 |
CN101291670A (zh) | 2008-10-22 |
BRPI0619308A2 (pt) | 2013-03-05 |
KR20080064848A (ko) | 2008-07-09 |
ATE485040T1 (de) | 2010-11-15 |
EA200801114A1 (ru) | 2009-02-27 |
NO341252B1 (no) | 2017-09-25 |
PT1948166E (pt) | 2011-01-19 |
SI1948166T1 (sl) | 2011-02-28 |
ZA200803118B (en) | 2011-11-30 |
EA014694B1 (ru) | 2010-12-30 |
KR101125820B1 (ko) | 2012-03-28 |
ES2354455T3 (es) | 2011-03-15 |
US8143303B2 (en) | 2012-03-27 |
DK1948166T3 (da) | 2011-01-31 |
CA2626646A1 (fr) | 2007-04-26 |
CY1111560T1 (el) | 2015-10-07 |
NO20081739L (no) | 2008-07-09 |
EP1948166A1 (fr) | 2008-07-30 |
PL1948166T3 (pl) | 2011-04-29 |
AU2006305502B2 (en) | 2009-11-26 |
WO2007046111A1 (fr) | 2007-04-26 |
DE602006017722D1 (de) | 2010-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1888541T1 (sl) | Benzo(d)izoksazol-3-il-aminske spojine in njihova uporaba kot ligandi vaniloidnega receptorja | |
WO2006132914A3 (fr) | Derives de cyclobutyl amine | |
IL190654A (en) | Methods of Methyl-Sulfonamido-Propanamido, Processes for Preparation and Medicines Containing Them | |
TW200510301A (en) | Novel compounds | |
TW200510303A (en) | Novel compounds | |
TW200728307A (en) | Novel spirochromanone derivatives | |
TW200740814A (en) | Compounds | |
PT1877367E (pt) | Derivados do acetileno | |
HK1116796A1 (en) | Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands | |
HK1135096A1 (en) | Process for preparing 6-phenoxypyrimidin-4-ol derivatives in the presence of a quinuclidine or a n-methyl pyrrolidine derivative | |
IL191751A0 (en) | Pyrrolo[2,3-c]pyridine derivatives | |
WO2007150010A3 (fr) | Dérivés de cyclopropylamines | |
WO2007021711A3 (fr) | Derives de 3-sulfonylindazole substitues en tant que ligands de 5-hydroxytryptamine-6 | |
MX2008002158A (es) | Derivados de azinil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6. | |
DK2155674T3 (da) | Aminoalkoxy-aryl-sulfonamidforbindelser og anvendelse heraf som 5-HT6-ligander | |
HK1120424A1 (en) | Carbazole derivatives as functional 5-ht6 ligands | |
TW200738611A (en) | 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments | |
TW200631952A (en) | Benzdioxan piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites | |
WO2008063548A3 (fr) | Dérivés de 3-(hétéro)arylisoquinolinamine substitués en position 5, 6, ou 7 et utilisation thérapeutique de ceux-ci | |
TW200633987A (en) | Phenylpiperazines with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites | |
WO2005097757A3 (fr) | Derives de nucleosides et leur utilisation therapeutique | |
WO2007109871A3 (fr) | Dérives d'acridine a activite antitumorale | |
WO2007079929A3 (fr) | Derives piperidone tricycliques substitues |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20200605 |